Page last updated: 2024-10-26

disulfiram and Nasopharyngeal Carcinoma

disulfiram has been researched along with Nasopharyngeal Carcinoma in 1 studies

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, Y1
Li, M1
Sun, X1
Zhou, C1
Wang, Y1
Wang, L1
Chen, L1
Liang, Z1
Zhu, L1
Yang, H1

Other Studies

1 other study available for disulfiram and Nasopharyngeal Carcinoma

ArticleYear
The selective cytotoxicity of DSF-Cu attributes to the biomechanical properties and cytoskeleton rearrangements in the normal and cancerous nasopharyngeal epithelial cells.
    The international journal of biochemistry & cell biology, 2017, Volume: 84

    Topics: Actins; Antineoplastic Agents; Apoptosis; Biomechanical Phenomena; Carcinoma; Cell Adhesion; Cell Cy

2017